Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
New funding transforms lives by expanding electricity access across Africa - 2Artemis 2 moon rocket gets 'America 250' paint job | Space photo of the day for Dec. 23, 2025
- 3Exploring the Market: Unsold Rams May Be Less expensive Than You Naturally suspect
- 4How Much Has the Iran War Cost the Average American Per Day?
- 5Understanding Successful Compromise Standards to Cultivate Agreeable Connections
- Hoist Your Style: Famous Hairdos for Ladies
- Consumer outlook on UK economy falls to two-year low
- ByHeart infant formula recall tied to botulism outbreak puts parents on edge
- Israeli naval intelligence reduces Iranian threat to Strait of Hormuz
- Figurine of a woman and a goose offers peek at prehistoric beliefs
- Vote in favor of your Number one natural product
- Cuba says 33 have died of mosquito-borne illnesses as epidemic rages
- Netflix is releasing a documentary on Elizabeth Smart. What to know about her kidnapping, rescue and where she is now.
- I tried a macho, creatine-loaded cereal “for men.” Did I mention I'm a woman?
